Latest ArticlesThis study aimed to investigate the cause of an unidentified peak that appeared ahead of the VP3 subunit peak during the purity analysis of adeno-associated virus(AAV) capsid subunits by capillary electrophoresis sodium dodecyl sulfate(CE-SDS) technique. Initially, a point mutation was introduced to the second start codon within the base sequence of the recombinant adeno-associated virus(rAAV) capsid protein’s VP3 subunit via PCR to generate a mutant rAAV. Subsequently, the relationship between this mutation and the unidentified signal peak was elucidated using CE-SDS technique. Additionally, the relative molecular weight and peptide analysis of the unknown peak was detected by LC-MS. The results indicated that if the VP3 subunit’s base sequence contain two initiation codons(ATG), the translation might start from the second initiation codon. And the expression product was a variant of the VP3 subunit(VP3'), which aligned with the unidentified signal peak observed in CE-SDS analysis. Consequently, this unidentified peak should be regarded as a AAV capsid subunit peak during the purity assessment of AAV capsid proteins.
Bioequivalence studies of suspension-based nasal sprays are challenging tasks for generic drug developers. Researchers should not only conduct consistency studies on the dosage and formulation characteristics of excipients in accordance with the requirements of the guidelines, but also need to use analytical tools to determine the consistency of key quality attributes such as particle size and particle size distribution of active pharmaceutical ingredients. This study explored the application of morphologically-directed Raman spectroscopy in the study of particle size distribution of nasal suspensions. The method has been approved by the U.S. FDA for the studies that substitute bioequivalence of clinical endpoints, which is critical for cost reduction and faster development for consistency evaluation of suspension-based nasal spray products.
The oral delivery of peptide and protein drugs has received widespread attention in recent years, and how to overcome gastrointestinal physiological barriers and improve bioavailability is a key issue in their clinical applications. Mesoporous silica is an artificially synthesized nanoscale inorganic porous material. Due to the unique properties, such as controllable particle size, pore size, morphology, and surface chemistry, mesoporous silica has the potential to serve as an oral delivery carrier for peptide and protein drugs. This article reviews the main barriers that hinder the oral absorption of peptides and protein drugs, the characteristics, synthesis, surface modification methods, and some recent advances of mesoporous silica, hoping to provide new ideas for the application of mesoporous silica to oral delivery of peptide and protein drugs.
Edoxaban(1), an oral inhibitor of coagulation factor Ⅹa(FⅩa), is clinically used for the treatment of venous thromboembolism complicated by undergoing orthopaedic surgery of the lower limbs. According to retrosynthetic analysis, 1 is mainly composed of three key intermediates, namely tert-butyl [(1R,2S,5S)-2-amino-5-(dimethylcarbamoyl)-cyclohexyl]carbamate(2), 5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylic acid(3), and 2-[(5-chloropyridin-2-yl)amino]-2-oxoethyl acetate(4). Among them, the synthesis of the cis-cyclohexanediamine fragment of 2 and the thiazole ring fragment of 3 is more difficult. The paper summarizes the schemes for the synthesis of cis-cyclohexanediamine fragments by azide salts(esters), photo-extension reaction, Burgess reagent and other starting materials, and the synthesis of the thiazole ring fragment by monocyanine and sulphur, Asinger reaction, Grignard reagent and trichloroacetophenonium salts, and briefly comments on the corresponding advantages and disadvantages.
Nanofiltration, as a technology without thermal effect is suitable for the purification and separation of heat-sensitive components of traditional Chinese medicines(TCM). However with the transition of separation environment from water to organic solution, the physical and chemical properties of nanofiltration separation layer change, which makes it difficult for the separation model suitable for aqueous solution environment to guide the orderly separation of organic solution. Based on the charge effect, dissolution-diffusion effect and pore size screening effect, combined with the properties and production rules of TCM components, the regulation rules of complex solution environment can be explored. In this paper, the application features and challenges of nanofiltration separation technology in the field of TCM are analyzed around the complex solution environment. The nanofiltration separation mechanism in complex solution environment is reviewed, which provide a reference for improving the applicability of nanofiltration technology.
The resolution process for schizophrenia candidate drug ulotaront hydrochloride(SEP-363856, 1) had been optimized in this study. By screening five common resolving agents, namely L-malic acid, L-lactic acid, L-tartaric acid, L-camphorsulfonic acid, and L-camphoric acid, the best one was determined to be L-tartaric acid, and the optimal equivalent was found to be 0.3. The recrystallization solvent and its amount were also optimized, and 25 volumes of anhydrous ethanol was used to obtain (S)-(5,7-dihydro-4H-thieno[2,3-c]pyran-7-yl)-N-methylmethylamine L-tartrate(8). Compound 8 was treated with aqueous potassium hydroxide and subsequent salt formation with HCl in ethyl acetate, then 1 was obtained with ee value of 99.0%. The optimized resolution yield increased from 27%(original research process) to 38%, and the total yield increased from 14%(original research process) to 21%.
Forced degradation tests of eldecalcitol API were conducted under acidic, alkaline, oxidative, light-exposed, and high-temperature conditions. Five degradation products were generated, namely (1R,2R,3R,5Z,7E)-2-(3-hydroxypropoxy)-9,10-secocholesta-5,7,10(19),24(25)-tetraene-1,3-diol(AD-1), (1R,2R,3R,5E,6Z,8Z)-2-(3-hydroxypropoxy)-9,10-secocholesta-5(10),6,8(9)-triene-1,3,25-triol(AD-2), (1R,2R,3R,5E,7E)-2-(3-hydroxypropoxy)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol(AD-3), (1R,2R,3R,5E,6E,8Z)-2-(3-hydroxypropoxy)-9,10-secocholesta-5(10),6,8(9)-triene-1,3,25-triol(AD-4) and (1R,2R,3R,14S,5E,6Z,8Z)-2-(3-hydroxypropoxy)-9,10-secocholesta-5(10),6,8(9)-triene-1,3,25-triol(AD-5). Among them, AD-1 and AD-5 were not found in literatures. This study developed synthetic routes for AD-1 and AD-5, and optimized the synthesis process for AD-4. The structures of these products were confirmed by 1H NMR, 13C NMR, and MS. This paper provides the references for the quality research of eldecalcitol, as well as its production, packaging, and storage.